NCT01162096View on ClinicalTrials.gov

Reduced Intensity Haploidentical Transplant for Hematological Malignancies

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

September 30, 2010

Study Completion Date

April 30, 2012

Conditions
Hematological Malignancies
Interventions
DEVICE

Haploidentical Allogeneic Transplantation

Patients undergoing reduced intensity haploidentical hematopoietic stem cell transplant from a partially matched related donor.

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

All Listed Sponsors
lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER

NCT01162096 - Reduced Intensity Haploidentical Transplant for Hematological Malignancies | Biotech Hunter | Biotech Hunter